Dupont Capital Management Corp Heron Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$2.66 - $5.37 $64,427 - $130,066	24,221 New	24,221 $102,000
Q4 2021 Jan 31, 2022	SELL	$8.35 - $12.6 $176,627 - $266,527	-21,153 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$10.13 - $15.0 $30,288 - $44,850	-2,990 Reduced 12.38%	21,153 $226,000
Q1 2021 Apr 29, 2021	SELL	$14.49 - $20.72 $71,754 - $102,605	-4,952 Reduced 17.02%	24,143 $391,000
Q4 2020 Jan 28, 2021	SELL	$14.61 - $22.14 $31,732 - $48,088	-2,172 Reduced 6.95%	29,095 $616,000
Q3 2020 Oct 29, 2020	SELL	$13.67 - $17.77 $28,624 - $37,210	-2,094 Reduced 6.28%	31,267 $463,000
Q2 2020 Jul 24, 2020	SELL	$10.89 - $21.47 $32,441 - $63,959	-2,979 Reduced 8.2%	33,361 $491,000
Q4 2019 Jan 27, 2020	BUY	$17.42 - $26.61 $633,042 - $967,007	36,340 New	36,340 $854,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.